{
  "context": {
    "rules": [
      "Rule1: Provided that the institution is authorized for research, then drug X is approved.",
      "Rule2: Under the condition that the grant has approved funding, drug X is approved.",
      "Rule3: Whenever bill 123 passes legislative vote, it becomes law.",
      "Rule4: Either bill 123 passes legislative vote or the president grants executive approval.",
      "Rule5: Provided that the president grants executive approval, then the grant has approved funding.",
      "Rule6: Whenever bill 123 becomes law, the FDA establishes guidelines.",
      "Rule7: If the FDA is created as an agency, then the institution is authorized for research.",
      "Rule8: Provided that the FDA establishes guidelines, then the FDA is created as an agency.",
      "Rule9: If the pharma company has exclusive rights, then drug X is approved.",
      "Rule10: Provided that the supplier engages in illegal import, then the supplier is a registered importer.",
      "Rule11: Whenever the supplier engages in illegal import, criminal charges are filed.",
      "Rule12: Either the supplier engages in illegal import or, if the pharma company has a patent, then it has exclusive rights.",
      "Rule13: Under the condition that the shipment is subject to customs seizure, then the supplier is not a registered importer.",
      "Rule14: If the FBI opens an investigation, then the shipment is subject to customs seizure.",
      "Rule15: Provided that criminal charges are filed, then the FBI opens an investigation.",
      "Rule16: Either the clinical trial phase is completed or the study passes peer review.",
      "Rule17: Whenever the study passes peer review, drug X is approved.",
      "Rule18: If an independent data audit is conducted, then, provided that the clinical trial phase is completed, drug X is approved.",
      "Rule19: Under the condition that the statistical analysis is valid, then, if the clinical trial phase is completed, drug X is approved.",
      "Rule20: Provided that the monitoring committee conducts a review, then an independent data audit is conducted.",
      "Rule21: Either the monitoring committee conducts a review or adverse events are reported.",
      "Rule22: Under the condition that a safety assessment is completed, then the statistical analysis is valid.",
      "Rule23: Provided that a protocol amendment is required, then the trial is suspended temporarily.",
      "Rule24: If a DSMB recommendation is issued, then, under the condition that it is not the case that if adverse events are reported then a safety assessment is completed, a protocol amendment is required.",
      "Rule25: Either a DSMB recommendation is issued or the FDA conducts a regulatory inspection.",
      "Rule26: Whenever the FDA conducts a regulatory inspection, then, provided that it is not the case that if adverse events are reported then a safety assessment is completed, a protocol amendment is required.",
      "Rule27: Either the quality control check fails or it is not the case that a manufacturing complaint is received.",
      "Rule28: Either a batch recall is initiated or it is not the case that the quality control check fails.",
      "Rule29: Either production is halted at the facility or it is not the case that a batch recall is initiated.",
      "Rule30: If the company makes a false claim, then it is not the case that the company violates a regulation.",
      "Rule31: Provided that a whistleblower report is submitted, then, under the condition that it is not the case that if it is not the case that the company makes a false claim then corrective action is taken, a warning letter is issued.",
      "Rule32: If a hearing is scheduled, then, under the condition that it is not the case that if it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data then the committee does not pass review, drug X gets market approval.",
      "Rule33: Whenever the company violates a regulation, then the company pays a fine.",
      "Rule34: Under the condition that the company violates a regulation, then it is not the case that the company pays a fine.",
      "Rule35: Either the company violates a regulation or either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing.",
      "Rule36: Under the condition that it is not the case that if adverse events are reported then a safety assessment is completed, then it is not the case that the trial is suspended temporarily.",
      "Rule37: Provided that it is not the case that either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing, then a manufacturing complaint is received.",
      "Rule38: Under the condition that it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data, then the committee passes review.",
      "Rule39: Whenever it is not the case that the company makes a false claim, then it is not the case that corrective action is taken.",
      "Rule40: If drug X is not approved, then the lab completes testing."
    ],
    "facts": [
      "Fact1: The pharma company has a patent.",
      "Fact2: A whistleblower report is submitted.",
      "Fact3: A hearing is scheduled.",
      "Fact4: It is not the case that clinical trials require approval.",
      "Fact5: It is not the case that drug X has safety data.",
      "Fact6: It is not the case that production is halted at the facility.",
      "Fact7: It is not the case that drug X gets market approval.",
      "Fact8: It is not the case that a warning letter is issued.",
      "Fact9: It is not the case that the manufacturer submits a report."
    ]
  },
  "question": "Drug X is approved."
}